Rutgers Recruiting Participants for Pfizer Pediatric Oral Antiviral COVID-19 Treatment Clinical Trial
May 13, 2022
May 13, 2022
NEW BRUNSWICK, New Jersey, May 13 (TNSRes) -- Rutgers University issued the following news:
Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the safety and efficacy of a potential oral antiviral treatment for children under 18 years with COVID-19 who have health conditions that put them at risk for severe illness.
The phase 2/3 clinical trial will evaluate the pharmacokinetics, safety and tolerability of the tr . . .
Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the safety and efficacy of a potential oral antiviral treatment for children under 18 years with COVID-19 who have health conditions that put them at risk for severe illness.
The phase 2/3 clinical trial will evaluate the pharmacokinetics, safety and tolerability of the tr . . .